Search & Filter

Metformin could be used to lower cholesterol levels, new research carried out at Helmholtz Zentrum München and the German Diabetes Centre in Dusseldorf has revealed.

Rivaroxaban may be an effective treatment option over warfarin for patients with atrial fibrillation (AF), regardless of diabetes status, research from the ROCKET-AF trial has revealed.

The American Society of Clinical Oncology (ASCO) has called on federal agencies and the cancer research community to broaden clinical trials to include older adults.

A new drug that blocks cancer's escape route from chemotherapy could be used to treat deadly lung and pancreatic cancers, according to new research.

A charity and medical experts are calling for the Scottish Medicines Consortium (SMC) to justify why it has decided not to recommend the use of XTANDI (enzalutamide) to treat adult men with metastatic castration-resistant prostate cancer (mCRPC) who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy, in whom chemotherapy is not yet clinically indicated.

Joining a religious organisation is more beneficial than charity work, sport or education in improving the mental health of older people in Europe, a study has found.

Following limited progress with dementia innovation efforts, the Department of Health has commissioned RAND Europe to examine breakthroughs in the treatment of other conditions and to identify potentially transferable and adaptable lessons for the dementia context.

The National Institute for Health and Care Excellence has recommended a new treatment to help prevent strokes and systemic embolism in patients suffering from the heart rhythm disorder atrial fibrillation with those over-75 a particular risk factor.

GPs have been warned to be on the look-out for 'diabulimia', or Eating Disorder-Diabetes Mellitus Type 1 (ED-DMT1), which is seen by some as a secret weapon for weight loss.

NICE has recommended Lixiana (edoxaban) for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation, saying it is a cost effective use of NHS resources.

According to new research commissioned by Age UK and the British Geriatrics Society, using the medical term 'frailty' can provoke a strongly negative reaction from older people, because of its associations with loss of independence and end of life.

In this article, Dr Harry Brown talks about what healthcare could look like in the future as the NHS continues to struggle with the ageing population.

Part one of the conference report of the GM Conference Ageing and Healthcare Today which took place in Edinburgh in June.

Parkinson's disease (PD) is a serious chronic neurodegenerative disease with no cure that affects all aspects of daily living.

The Institute of Cancer Research has voiced its disappointment at the recent NICE decision on olaparib for women with BRCA mutated ovarian cancer in further draft guidance.